Keudell/Morrison Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Keudell/Morrison Wealth Management's LLY Position: Q3 2026 in Review
Keudell/Morrison Wealth Management increased its Eli Lilly (LLY) stake by 0.6% in Q3 2026, buying an estimated $35.4K and bringing the position to 5,019 shares worth $5.81M. The position accounts for 1.03% of the portfolio, ranked #24.
Keudell/Morrison Wealth Management first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.98M in Q2 2026. 3,807 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Keudell/Morrison Wealth Management held 5,019 shares of Eli Lilly worth $5.81M as of Q3 2026.
- Keudell/Morrison Wealth Management bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
- Eli Lilly made up 1.03% of Keudell/Morrison Wealth Management's portfolio in Q3 2026, its #24 holding.
- Keudell/Morrison Wealth Management first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
- Keudell/Morrison Wealth Management's Eli Lilly position peaked at $5.98M in Q2 2026.
- 3,807 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Keudell/Morrison Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.